Genetic events in the pathogenesis of multiple myeloma

W. J. Chng, O. Glebov, Peter Leif Bergsagel, W. M. Kuehl

Research output: Contribution to journalArticle

140 Citations (Scopus)

Abstract

The genetics of myeloma has been increasingly elucidated in recent years. Recurrent genetic events, and also biologically distinct and clinically relevant genetic subtypes of myeloma have been defined. This has facilitated our understanding of the molecular pathogenesis of the disease. In addition, some genetic abnormalities have proved to be highly reproducible prognostic factors. With the expanding therapeutic armamentarium, it is time to include genetic assessment as part of clinical evaluation of myeloma patients to guide management. In this review we examine the role of various genetic abnormalities in the molecular pathogenesis of myeloma, and the use of such abnormalities in disease classification, prognosis and clinical management.

Original languageEnglish (US)
Pages (from-to)571-596
Number of pages26
JournalBest Practice and Research: Clinical Haematology
Volume20
Issue number4
DOIs
StatePublished - Dec 2007

Fingerprint

Multiple Myeloma
Therapeutics
Genetics

Keywords

  • gene expression profiling
  • genetics
  • hyperdiploid
  • IgH translocations
  • molecular pathogenesis
  • prognosis

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Genetic events in the pathogenesis of multiple myeloma. / Chng, W. J.; Glebov, O.; Bergsagel, Peter Leif; Kuehl, W. M.

In: Best Practice and Research: Clinical Haematology, Vol. 20, No. 4, 12.2007, p. 571-596.

Research output: Contribution to journalArticle

Chng, W. J. ; Glebov, O. ; Bergsagel, Peter Leif ; Kuehl, W. M. / Genetic events in the pathogenesis of multiple myeloma. In: Best Practice and Research: Clinical Haematology. 2007 ; Vol. 20, No. 4. pp. 571-596.
@article{48a8f54e1deb4e268408be50f628e72f,
title = "Genetic events in the pathogenesis of multiple myeloma",
abstract = "The genetics of myeloma has been increasingly elucidated in recent years. Recurrent genetic events, and also biologically distinct and clinically relevant genetic subtypes of myeloma have been defined. This has facilitated our understanding of the molecular pathogenesis of the disease. In addition, some genetic abnormalities have proved to be highly reproducible prognostic factors. With the expanding therapeutic armamentarium, it is time to include genetic assessment as part of clinical evaluation of myeloma patients to guide management. In this review we examine the role of various genetic abnormalities in the molecular pathogenesis of myeloma, and the use of such abnormalities in disease classification, prognosis and clinical management.",
keywords = "gene expression profiling, genetics, hyperdiploid, IgH translocations, molecular pathogenesis, prognosis",
author = "Chng, {W. J.} and O. Glebov and Bergsagel, {Peter Leif} and Kuehl, {W. M.}",
year = "2007",
month = "12",
doi = "10.1016/j.beha.2007.08.004",
language = "English (US)",
volume = "20",
pages = "571--596",
journal = "Best Practice and Research in Clinical Haematology",
issn = "1521-6926",
publisher = "Bailliere Tindall Ltd",
number = "4",

}

TY - JOUR

T1 - Genetic events in the pathogenesis of multiple myeloma

AU - Chng, W. J.

AU - Glebov, O.

AU - Bergsagel, Peter Leif

AU - Kuehl, W. M.

PY - 2007/12

Y1 - 2007/12

N2 - The genetics of myeloma has been increasingly elucidated in recent years. Recurrent genetic events, and also biologically distinct and clinically relevant genetic subtypes of myeloma have been defined. This has facilitated our understanding of the molecular pathogenesis of the disease. In addition, some genetic abnormalities have proved to be highly reproducible prognostic factors. With the expanding therapeutic armamentarium, it is time to include genetic assessment as part of clinical evaluation of myeloma patients to guide management. In this review we examine the role of various genetic abnormalities in the molecular pathogenesis of myeloma, and the use of such abnormalities in disease classification, prognosis and clinical management.

AB - The genetics of myeloma has been increasingly elucidated in recent years. Recurrent genetic events, and also biologically distinct and clinically relevant genetic subtypes of myeloma have been defined. This has facilitated our understanding of the molecular pathogenesis of the disease. In addition, some genetic abnormalities have proved to be highly reproducible prognostic factors. With the expanding therapeutic armamentarium, it is time to include genetic assessment as part of clinical evaluation of myeloma patients to guide management. In this review we examine the role of various genetic abnormalities in the molecular pathogenesis of myeloma, and the use of such abnormalities in disease classification, prognosis and clinical management.

KW - gene expression profiling

KW - genetics

KW - hyperdiploid

KW - IgH translocations

KW - molecular pathogenesis

KW - prognosis

UR - http://www.scopus.com/inward/record.url?scp=36749027626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36749027626&partnerID=8YFLogxK

U2 - 10.1016/j.beha.2007.08.004

DO - 10.1016/j.beha.2007.08.004

M3 - Article

VL - 20

SP - 571

EP - 596

JO - Best Practice and Research in Clinical Haematology

JF - Best Practice and Research in Clinical Haematology

SN - 1521-6926

IS - 4

ER -